Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
XRAY · against 1,216 other Healthcare companies
Ranked #944 of 1,217 · scores higher than 22% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including XRAY · Click a bar to see the companies
Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | XRAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -3.0% | 6.1% | 24% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -2.1% | 5.8% | 23% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 944 | 1.7B USD | 22 | 44 | |
| 944 | 131M CAD (≈$96M) | 22 | 40 | |
| 944 | 14.8B MXN (≈$800M) | 22 | 61 | |
| 944 | 213M EUR (≈$235M) | 22 | 40 | |
| 944 | 1.9B USD | 22 | 38 | |
| 956 | 10.6B CNY (≈$1.5B) | 21 | 43 | |
| 956 | 3.0B CNY (≈$427M) | 21 | 36 | |
| 956 | 1.43T KRW (≈$1.0B) | 21 | 55 | |
| 956 | 2.1B CNY (≈$301M) | 21 | 21 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score